Comparison between intravesical BCG therapy and intravesical BCG and MMC therapy for prevention of recurence and treatment of in situ cancer in non-muscle invasive bladder cancer patients with intermediate or high risk disease.
Not Applicable
- Conditions
- Bladder cancer
- Registration Number
- JPRN-UMIN000024162
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 284
Inclusion Criteria
Not provided
Exclusion Criteria
1: The chance of living over 6 months 2: With active tuberculosis 3: Allergy for BCG or MMC 4: With other maligancy or has plan of treatment for the disease. 5: The doctor judged as improper.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method